Safinamide
ATC N04BD03 · 9 markets · 53 records
GB 14 records · 2 strengths
- 50 mgtabletXadagoManufacturer: A A H Pharmaceuticals Ltd、Manufacturer: Alliance Healthcare (Distri…、Manufacturer: Amarox Ltd、Manufacturer: Celix Pharma Ltd、Manufacturer: MSN Laboratories Europe Ltd
- 100 mgtabletXadagoManufacturer: A A H Pharmaceuticals Ltd、Manufacturer: Alliance Healthcare (Distri…、Manufacturer: Amarox Ltd、Manufacturer: Celix Pharma Ltd、Manufacturer: MSN Laboratories Europe Ltd
ES 13 records · 2 strengths
- 50 mgtabletSAFINAMIDA VIVANTAXadago
- 100 mgtabletSAFINAMIDA VIVANTAXadago
AU 8 records · 3 strengths
- 50 mgtabletARX-SafinamideXadago、XAFIMED
- 100 mgtabletARX-SafinamideXadago、XAFIMED
Records without a stated strength · 1 ARX-Safinamide、XAFIMED
US 2 records · 2 strengths
CA 2 records · 2 strengths
SG 1 records · 1 strengths
- 50 mgtabletEqufina Tablets 50 mg
MX 1 records · 1 strengths
Records without a stated strength · 1 Xadago
HK 1 records · 1 strengths
Records without a stated strength · 1 Equfina Tablets 50 mg
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Xadago
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 50 mg tablet | Xadago | Manufacturer: A A H Pharmaceuticals Ltd ×2 Manufacturer: Alliance Healthcare (Distri… ×2 Manufacturer: Amarox Ltd ×2+3Manufacturer: Celix Pharma Ltd ×2 Manufacturer: MSN Laboratories Europe Ltd ×2 Xadago | ONSTRYV | ARX-Safinamide Xadago XAFIMED | Equfina Tablets 50 mg | SAFINAMIDA VIVANTA Xadago | |||
| 100 mg tablet | Xadago | Manufacturer: A A H Pharmaceuticals Ltd ×2 Manufacturer: Alliance Healthcare (Distri… ×2 Manufacturer: Amarox Ltd ×2+3Manufacturer: Celix Pharma Ltd ×2 Manufacturer: MSN Laboratories Europe Ltd ×2 Xadago | ONSTRYV | ARX-Safinamide Xadago XAFIMED | SAFINAMIDA VIVANTA Xadago | ||||
unknown | ARX-Safinamide XAFIMED | Equfina Tablets 50 mg | Xadago | ||||||
tablet | Xadago |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.